By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



150 Orchard Road
Orchard Plaza 08-02
  Singapore  238841   Singapore
Phone: n/a Fax: n/a



Company News
VolitionRX Wins First CE Mark for NuQ Blood Assay for Colorectal Cancer Detection 9/22/2015 6:02:03 AM
VolitionRX Granted Its First U.S. Patent 9/10/2015 6:11:19 AM
VolitionRX Demonstrates Nuq Blood Test Detects 81% Of Colorectal Cancers And 67% Of High Risk Adenomas In Large Double Blinded Clinical Trial 9/9/2015 6:23:39 AM
VolitionRX To Present At Rodman & Renshaw 17th Annual Global Investment Conference In New York And CNAPS IX Conference In Berlin On September 9 And 11, 2015 9/2/2015 8:58:35 AM
VolitionRX To Attend 10th Annual Wells Fargo Healthcare Conference On September 9-10, 2015 9/1/2015 8:05:10 AM
VolitionRX Announces Appointment Of David Kratochvil As Chief Financial Officer 8/17/2015 6:24:34 AM
VolitionRX Announces Second Quarter 2015 Financial Results And Business Update 8/11/2015 10:38:27 AM
VolitionRX Schedules Second Quarter 2015 Earnings Conference Call And Business Update For Tuesday, August 11, 2015 At 8:30am ET 8/5/2015 8:14:25 AM
VolitionRX To Present At Wedbush PacGrow Healthcare Conference 8/3/2015 9:46:51 AM
VolitionRX Engages Specialty Clinical Research Organization To Support Initial Entry Of Its Nuq Colorectal Cancer Tests Via U.S. CLIA Labs 7/27/2015 10:35:22 AM